Abstract
DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Keywords: Neurones, heterogeneous, myelination
Current Neuropharmacology
Title: Cannabinoids and Sensory Neurones
Volume: 2 Issue: 1
Author(s): Ruth A. Ross, Rhian M. Evans and Roderick H. Scott
Affiliation:
Keywords: Neurones, heterogeneous, myelination
Abstract: DRG neurones are a heterogeneous population of neurones that vary in sensory transduction mechanisms, myelination, axon diameter, cell soma size, neurotransmitter content, receptor and ion channel expression. The generation, conduction, integration and transmission of pain signals begin in DRG neurones and they remain an important target for therapeutic intervention in pain disorders. In this review we discuss the expression of cannabinoid receptors in DRG neurones. We will also discuss the actions and molecular mechanisms of cannabinoid receptor ligands in the context of modulating sensory neurone excitability. Evidence suggests that vanilloid and cytokine receptor functions, voltageactivated Ca2+ and K + channels and Ca2+-activated channels are all either direct or indirect sites that might be modulated by synthetic and endogenous cannabinoid ligands.
Export Options
About this article
Cite this article as:
Ross A. Ruth, Evans M. Rhian and Scott H. Roderick, Cannabinoids and Sensory Neurones, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476882
DOI https://dx.doi.org/10.2174/1570159043476882 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity
Current Pharmaceutical Design Stem Cell Regenerative Potential Combined with Nanotechnology and Tissue Engineering for Myocardial Regeneration
Current Stem Cell Research & Therapy Chemosensitization of Prostate Carcinoma Cells with a Receptor-directed Smac Conjugate
Medicinal Chemistry Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Effect of PUFAs Oral Administration on the Amount of Apoptotic Caspases Enzymes in Gastric Cancer Patients Undergoing Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development
Current Cancer Drug Targets Antidepressants, β-Arrestins and GRKs: From Regulation of Signal Desensitization to Intracellular Multifunctional Adaptor Functions
Current Pharmaceutical Design Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity
Current Organic Chemistry The Past, Current Studies and Future of Organometallic <sup>99m</sup>Tc(CO)3 Labeled Peptides and Proteins
Current Pharmaceutical Design Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System
Current Neuropharmacology Marine Natural Products with High Anticancer Activities
Current Medicinal Chemistry TNF α Signaling Beholds Thalidomide Saga: A Review of Mechanistic Role of TNF-α Signaling Under Thalidomide
Current Topics in Medicinal Chemistry Antiangiogenic Drugs and Tyrosine Kinases
Anti-Cancer Agents in Medicinal Chemistry Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Peptide Toxins that Target Ion Channels
Inflammation & Allergy - Drug Targets (Discontinued) Editorial (Thematic Issue: Emerging Concepts and Therapeutics Strategies for the Treatment of Brain Tumors)
Anti-Cancer Agents in Medicinal Chemistry The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design